Clinical Trials Directory

Trials / Completed

CompletedNCT05230095

Social Cognition Dysfunctions in Parkinson's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

Parkinson's disease (PD) is usually responsible of cognitive and behavioral non-motor signs with a major impact on the quality of life. Social cognition is a complex system relying on emotion recognition (neurons mirror system (NMS)), the theory of mind (with its two parts: emotional and cognitive), but also on the social and cultural environment and the personal history. The first step in this model is represented by the NMS, which seems to be altered in PD patients for both positive and negative emotions as shown in our preliminary study. The investigator purpose is to investigate the role of the treatment (levodopa and deep brain stimulation) on the functioning of the NMS

Conditions

Interventions

TypeNameDescription
BEHAVIORALsocial cognition testsThe evaluation of social cognition will be carried out using questionnaires and a point lights computer test. During the computer test, participants have to watch several short sequences of interactions between two silhouettes and give an interpretation of the scene. Patients will be evaluated twice: one time before the surgery and a second time 1 year after surgery. Healthy volunteers will be evaluated only one time.
BEHAVIORALQuality of life self-questionnaireQuality of life will be assessed using a self-administered questionnaire in the patients group only.

Timeline

Start date
2022-04-11
Primary completion
2024-01-23
Completion
2024-01-23
First posted
2022-02-08
Last updated
2024-02-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05230095. Inclusion in this directory is not an endorsement.